{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T20:54:47Z","timestamp":1773348887793,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T00:00:00Z","timestamp":1654473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T00:00:00Z","timestamp":1654473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trop Dis Travel Med Vaccines"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>The Kenya Breaking Transmission Strategy for Neglected Tropical Diseases (NTD) from 2019 to 2023 intensifies advocacy, coordination, and partnerships. The purpose of this study was to explore views and experiences of stakeholders and health workers on ways of improving the Advocacy, Communication and Social Mobilization (ACSM) activities of Mass Drug Administration (MDA) for Lymphatic Filariasis (LF) programs through participatory approaches in Kilifi County, Kenya.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Two wards were purposely selected in the Kaloleni sub-county, Kilifi County, where there was an average treatment coverage of 56% in 2015, 50.5% in 2016. Qualitative data collection methods were employed, which included participatory meetings with county stakeholders to understand their views, experiences, and suggestions on how ACSM strategies can be improved in MDA for LF. Twelve In-Depth Interviews (IDIs) were conducted (six with opinion leaders and six with Community Health Extension Workers (CHEWs) and two semi-structured interviews (SSIs) were held with county and sub-county coordinators involved in MDA administration. The aim was to better to understand their perceptions of the NTD program about ACSM, challenges to ACSM strategies, and ways to improve the strategies for ACSM in MDA for LF. The Data was organized and classified into codes and themes using QSR NVIVO version 12.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The study observed the low participation of stakeholders in the ACSM activities of MDA for LF and identified potential areas for stakeholders\u2019 involvement to strengthen the activities. Challenges hindering effective implementation of ACSM activities include late delivery of Information, Educational and Communication (IEC) and few IEC materials, insufficient funding, inadequate time allocated to reach the assigned households with messages, messaging, and packaging of information for dissemination due to the vastness of the area. The stakeholders recommended innovative strategies and techniques to improve ACSM activities.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion and conclusion<\/jats:title>\n                <jats:p>The results of this study show key challenges to ACSM implementation of MDA for LF. Implementers need to pay attention to these challenges to enhance the effectiveness of MDA per the Kenya NTD Breaking Transmission Strategy. ACSM efforts in MDA for LF control and elimination should be linked with overarching efforts to mainstream partnerships and coordination in control and elimination.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40794-022-00172-8","type":"journal-article","created":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T06:02:29Z","timestamp":1654495349000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Towards elimination of Lymphatic Filariasis in Kenya: improving advocacy, communication and social mobilization activities for mass drug administration, a qualitative study"],"prefix":"10.1186","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8500-8500","authenticated-orcid":false,"given":"Lydiah W.","family":"Kibe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bridget W.","family":"Kimani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Collins","family":"Okoyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wyckliff P.","family":"Omondi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hadley M.","family":"Sultani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doris W.","family":"Njomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,6]]},"reference":[{"key":"172_CR1","volume-title":"Global programme to eliminate lymphatic filariasis: progress report, 2017","author":"World Health Organization","year":"2018","unstructured":"World Health Organization. Global programme to eliminate lymphatic filariasis: progress report, 2017. Geneva: WHO; 2018. Contract No.: 44"},{"issue":"8","key":"172_CR2","doi-asserted-by":"publisher","first-page":"e412","DOI":"10.1371\/journal.pntd.0000412","volume":"3","author":"PJ Hotez","year":"2009","unstructured":"Hotez PJ, Kamath A. Neglected tropical diseases in sub-Saharan Africa: review of their prevalence, distribution, and disease burden. PLoS Negl Trop Dis. 2009;3(8):e412.","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"172_CR3","first-page":"e154","volume":"4","author":"MJ Bockarie","year":"2016","unstructured":"Bockarie MJ, Rebollo M. Reducing the population requiring interventions against lymphatic filariasis in Africa. The Lancet. Glob Health. 2016;4(3):e154\u2013e5.","journal-title":"Glob Health"},{"key":"172_CR4","doi-asserted-by":"crossref","unstructured":"Gyapong J, Boatin B. Neglected tropical diseases-sub-Saharan Africa. New York Dordrecht London: Springer International Publishing; 2016.","DOI":"10.1007\/978-3-319-25471-5"},{"issue":"4","key":"172_CR5","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/S1473-3099(16)30544-8","volume":"17","author":"ML Ndeffo-Mbah","year":"2017","unstructured":"Ndeffo-Mbah ML, Galvani AP. Global elimination of lymphatic filariasis. Lancet Infect Dis. 2017;17(4):358\u20139.","journal-title":"Lancet Infect Dis"},{"key":"172_CR6","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1186\/s13071-015-1166-x","volume":"8","author":"P Moraga","year":"2015","unstructured":"Moraga P, Cano J, Baggaley RF, Gyapong JO, Njenga SM, Nikolay B, et al. Modelling the distribution and transmission intensity of lymphatic filariasis in sub-Saharan Africa prior to scaling up interventions: integrated use of geostatistical and mathematical modelling. Parasit Vectors. 2015;8:560.","journal-title":"Parasit Vectors"},{"issue":"1","key":"172_CR7","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13071-017-2044-5","volume":"10","author":"SM Njenga","year":"2017","unstructured":"Njenga SM, Kanyi HM, Mutungi FM, Okoyo C, Matendechero HS, Pullan RL, et al. Assessment of lymphatic filariasis prior to re-starting mass drug administration campaigns in coastal Kenya. Parasit Vectors. 2017;10(1):99.","journal-title":"Parasit Vectors"},{"key":"172_CR8","volume-title":"Kenya population and housing census: analytical report on population projections","author":"Kenya National Bureau of Statistics","year":"2009","unstructured":"Kenya National Bureau of Statistics. Kenya population and housing census: analytical report on population projections. Nairobi: KNBS; 2009. Available: http:\/\/www.knbs.or.ke\/index.php? option=com_phocadownload&view=category&id=109:population-and-housing-census-2009&Itemid=599. Accessed 29 Nov 2017. Contract No: 5th Feb 2021"},{"key":"172_CR9","volume-title":"The Kenya national breaking transmission strategy for soil-transmitted Helminthiasis, Schistosomiasis, Lymphatic Filariasis and Trachoma 2019-20233. Strategy","author":"Ministry of Health","year":"2019","unstructured":"Ministry of Health. The Kenya national breaking transmission strategy for soil-transmitted Helminthiasis, Schistosomiasis, Lymphatic Filariasis and Trachoma 2019-20233. Strategy. Nairobi: Ministry of Health, DVB-NTD; 2019."},{"issue":"1","key":"172_CR10","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1186\/s12889-017-4414-5","volume":"17","author":"A Silumbwe","year":"2017","unstructured":"Silumbwe A, Zulu JM, Halwindi H, Jacobs C, Zgambo J, Dambe R, et al. A systematic review of factors that shape implementation of mass drug administration for lymphatic filariasis in sub-Saharan Africa. BMC Public Health. 2017;17(1):484.","journal-title":"BMC Public Health"},{"issue":"1","key":"172_CR11","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s13071-019-3497-5","volume":"12","author":"FN Dissak-Delon","year":"2019","unstructured":"Dissak-Delon FN, Kamga G-R, Humblet PC, Robert A, Souopgui J, Kamgno J, et al. Barriers to the National onchocerciasis control programme at operational level in Cameroon: a qualitative assessment of stakeholders\u2019 views. Parasit Vectors. 2019;12(1):246.","journal-title":"Parasit Vectors"},{"issue":"11","key":"172_CR12","doi-asserted-by":"publisher","first-page":"e2447","DOI":"10.1371\/journal.pntd.0002447","volume":"7","author":"A Krentel","year":"2013","unstructured":"Krentel A, Fischer PU, GJ. W. A review of factors that influence individual compliance with mass drug administration for elimination of lymphatic filariasis. PLoS Negl Trop Dis. 2013;7(11):e2447.","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"172_CR13","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40249-020-0638-1","volume":"9","author":"C Kusi","year":"2020","unstructured":"Kusi C, Steinmann P, Merten S. The fight against lymphatic filariasis: perceptions of community drug distributors during mass drug administration in coastal Kenya. Infect Dis Poverty. 2020;9(1):22.","journal-title":"Infect Dis Poverty"},{"key":"172_CR14","unstructured":"Jackson K, Bazeley P. Qualitative Data Analysis With NVivo. 3rd ed. Thousand Oaks: Sage Publications; 2019."},{"key":"172_CR15","volume-title":"Physical activityand health of youth","author":"R Malina","year":"2010","unstructured":"Malina R. Physical activityand health of youth. Constanta: Ovidius University Annals. Series Physical Education and Sport\/Science (Movement and Health); 2010."},{"issue":"9708","key":"172_CR16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0140-6736(09)61749-9","volume":"375","author":"B Liese","year":"2010","unstructured":"Liese B, Rosenberg M, Schratz A. Progmmes, partnerships, and governance for elimination and control of neglected tropical diseases. Lancet. 2010;375(9708):67\u201376.","journal-title":"Lancet"},{"issue":"11","key":"172_CR17","doi-asserted-by":"publisher","first-page":"e0007861","DOI":"10.1371\/journal.pntd.0007861","volume":"13","author":"A Silumbwe","year":"2019","unstructured":"Silumbwe A, Halwindi H, Zulu JM. How community engagement strategies shape participation in mass drug administration programmes for lymphatic filariasis: the case of Luangwa District, Zambia. PLoS Negl Trop Dis. 2019;13(11):e0007861.","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"172_CR18","doi-asserted-by":"publisher","first-page":"e2080","DOI":"10.1371\/journal.pntd.0002080","volume":"7","author":"YK Sodahlon","year":"2013","unstructured":"Sodahlon YK, Dorkenoo AM, Morgah K, Nabiliou K, Agbo K, Miller R. A success story: Togo is moving toward becoming the first Sub-Saharan African Nation to eliminate Lymphatic Filariasis through mass drug administration and Countrywide morbidity alleviation. PLoS Negl Trop Dis. 2013;7(4):e2080.","journal-title":"PLoS Negl Trop Dis"},{"issue":"12","key":"172_CR19","doi-asserted-by":"publisher","first-page":"e0009012","DOI":"10.1371\/journal.pntd.0009012","volume":"14","author":"DW Njomo","year":"2020","unstructured":"Njomo DW, Kimani BW, Kibe LW, Okoyo C, Omondi WP, Sultani H. Implementation challenges and opportunities for improved mass treatment uptake for lymphatic filariasis elimination: Perceptions and experiences of community drug distributors of coastal Kenya. PLoS Negl Trop Dis. 2020;14(12):e0009012.","journal-title":"PLoS Negl Trop Dis"},{"issue":"9","key":"172_CR20","doi-asserted-by":"publisher","first-page":"e0008499","DOI":"10.1371\/journal.pntd.0008499","volume":"14","author":"DW Njomo","year":"2020","unstructured":"Njomo DW, Kibe LW, Kimani BW, Okoyo C, Omondi WP, Sultani H. Addressing barriers of community participation and access to mass drug administration for lymphatic filariasis elimination in Coastal Kenya using a participatory approach. PLoS Negl Trop Dis. 2020;14(9):e0008499.","journal-title":"PLoS Negl Trop Dis"},{"issue":"12","key":"172_CR21","doi-asserted-by":"publisher","first-page":"e0006065","DOI":"10.1371\/journal.pntd.0006065","volume":"11","author":"A Krentel","year":"2017","unstructured":"Krentel A, Gyapong M, Mallya S, Boadu NY, Amuyunzu-Nyamongo M, Stephens M, et al. Review of the factors influencing the motivation of community drug distributors towards the control and elimination of neglected tropical diseases (NTDs). PLoS Negl Trop Dis. 2017;11(12):e0006065.","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"172_CR22","first-page":"1","volume":"11","author":"S Kelly","year":"2016","unstructured":"Kelly S, Martin S, Kuhn I, Cowan A, Brayne C, Lafortune L. Barriers and facilitators to the uptake and maintenance of healthy behaviours by people at mid-life: a rapid systematic review. PLoS One. 2016;11(1):1\u201326.","journal-title":"PLoS One"},{"issue":"3","key":"172_CR23","doi-asserted-by":"publisher","first-page":"e1574","DOI":"10.1371\/journal.pntd.0001574","volume":"6","author":"M Demb\u00e9l\u00e9","year":"2012","unstructured":"Demb\u00e9l\u00e9 M, Bamani S, Demb\u00e9l\u00e9 R, Traor\u00e9 MO, Goita S, Traor\u00e9 MN, et al. Implementing preventive chemotherapy through an integrated national neglected tropical disease control program in Mali. PLoS Negl Trop Dis. 2012;6(3):e1574.","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"172_CR24","doi-asserted-by":"publisher","first-page":"e83413","DOI":"10.1371\/journal.pone.0083413","volume":"9","author":"DW Njomo","year":"2014","unstructured":"Njomo DW, Mukoko DA, Nyamongo NK, Karanja J. Increasing coverage in mass drug administration for Lymphatic Filariasis elimination in an urban setting: a study of Malindi Town, Kenya. PLoS One. 2014;9(1):e83413.","journal-title":"PLoS One"},{"key":"172_CR25","volume-title":"Child health and development: information, education, and communication","author":"World Health Organization","year":"2017","unstructured":"World Health Organization. Child health and development: information, education, and communication 2017."},{"key":"172_CR26","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/1756-3305-3-120","volume":"3","author":"MH Hodges","year":"2010","unstructured":"Hodges MH, Smith SJ, Fussum D, Koroma JB, Conteh A, Sonnie M, et al. High coverage of mass drug administration for lymphatic filariasis in rural and non-rural settings in the Western Area, Sierra Leone. Parasit Vectors. 2010;3:120.","journal-title":"Parasit Vectors"},{"issue":"Supplement","key":"172_CR27","first-page":"S55","volume":"13","author":"A Krentel","year":"2021","unstructured":"Krentel A, Gyapong M, McFarland DA, Ogundahunsi O, Titaley CR, Addiss DG. Keeping communities at the centre of efforts to eliminate lymphatic filariasis: learning from the past to reach a future free of lymphatic filariasis. Int Health. 2021;13(Supplement):S55\u2013S9.","journal-title":"Int Health"},{"key":"172_CR28","unstructured":"World Health Organization and the United Nations Children\u2019s Fund (UNICEF). Community-based health care, including outreach and campaigns, in the context of the COVID-19 pandemic. Geneva: WHO; 2020.\u00a0 https:\/\/www.who.int\/publications-detail\/community-based-health-care-including-outreach-and-campaigns-in-the-context-of-the-covid-19-pandemic."}],"container-title":["Tropical Diseases, Travel Medicine and Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40794-022-00172-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40794-022-00172-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40794-022-00172-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T18:06:30Z","timestamp":1654538790000},"score":1,"resource":{"primary":{"URL":"https:\/\/tdtmvjournal.biomedcentral.com\/articles\/10.1186\/s40794-022-00172-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,6]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["172"],"URL":"https:\/\/doi.org\/10.1186\/s40794-022-00172-8","relation":{},"ISSN":["2055-0936"],"issn-type":[{"value":"2055-0936","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,6]]},"assertion":[{"value":"13 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical clearance was received from the Kenya Medical Research Institute (KEMRI), Scientific and Ethics Review Unit (SERU) Protocol Number 3666. Written informed consent was sought from all the study participants. All the participants were adults above the age of 18\u2009years.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval and Consent to participate"}},{"value":"Informed consent was obtained from all individual participants included in the study. This study has been published with the permission of the Director-General, KEMRI.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No conflict of interest is declared.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16"}}